Shareable Research Card

CYTOF - Altamira Therapeutics Ltd. Liabilities

This metric view shows CYTOF - Altamira Therapeutics Ltd. liabilities history from SEC company facts.

Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.

Context: Latest reported period: Q4 2024
Latest reported value: $2,087,030

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Open stable link Open company facts

Return Loop

Why revisit this metric view

This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.

Latest source-backed update: Latest period end 31 Dec 2024
Why come back: Return after the next filing to verify whether this metric changed and how it compares with the ranking page.

Current latest reported period: Q4 2024.
Latest reported value on this page: $2,087,030.
Save this filer if you want to compare the next reported value with this history.

Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.

Create account to save this filer Open company facts

Latest update

Latest update for Liabilities

New fact period available

Latest reported liabilities: $2,087,030. Open the source-backed page to compare this metric with the newest filing-backed context.

Update date

31 Dec 2024

Page type

Metric history

Latest period

Q4 2024

SEC-backed company facts were refreshed from filings filed on 30 Apr 2025.

Open recent updates hub Open company facts

Benchmark Context

How Liabilities compares with peers

Altamira Therapeutics Ltd. is outside the visible top 120 companies for liabilities in the current sample.

Compared with

Compared with 120 companies reporting liabilities in USD. This keeps the comparison on the same metric and unit family.

Why this is notable

This is about 0x the current sample midpoint. Liabilities is up about 42% versus the comparable prior period.

Visible rows currently span reported period ends from 31 Dec 2017 to 31 Dec 2025.
Nearby companies in this sample: HSBC HOLDINGS PLC and UBS AG.
Peer rows use the latest valid value per company for this exact metric and compatible units.

Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.

Open company facts

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it

Financial Metric Page

Altamira Therapeutics Ltd.: Liabilities

Latest period: Q4 2024. Period end: 31 Dec 2024. Units: USD and CHF. Frequency: quarterly.

Liabilities is an SEC-reported metric from company XBRL facts.

Metric Snapshot

Latest value: $2,087,030
Coverage range: 31 Dec 2016 - 31 Dec 2024
Fact rows: 17

View Financial Facts Overview

What This Metric Tells You

Shows the reported level of liabilities over 31 Dec 2016 - 31 Dec 2024.
Includes year-over-year change points to highlight acceleration or slowdown.
Built from 17 SEC fact rows for this metric and issuer.

How To Read This Chart

Start with the latest point, then compare it with the prior periods to see direction.
Use quarterly sequence to compare like-for-like periods.
Use YoY change bars to separate growth from contraction across matching periods.

Official SEC Source

Source: SEC Company Facts

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.

Direct filing link is shown only when a matched SEC filing document is available for this metric context.

Compare This Metric Across Companies

Compare latest available Liabilities levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

Rank	Company	Latest value	Reported period	Next step
1	HSBC HOLDINGS PLC (hsbc)	$3,027,368,000,000	Instant - 31 Dec 2025	Open HSBC HOLDINGS PLC Liabilities
2	UBS AG (amub)	$1,527,994,000,000	Instant - 31 Dec 2025	Open UBS AG Liabilities
3	UBS Group AG (ubs)	$1,526,944,000,000	Instant - 31 Dec 2025	Open UBS Group AG Liabilities
4	KB Financial Group Inc. (kb)	$472,325,085,000	Instant - 31 Dec 2024	Open KB Financial Group Inc. Liabilities
5	BROOKFIELD Corp /ON/ (bn)	$352,777,000,000	Instant - 31 Dec 2025	Open BROOKFIELD Corp /ON/ Liabilities
6	WOORI FINANCIAL GROUP INC. (wf)	$331,433,053,000	Instant - 31 Dec 2024	Open WOORI FINANCIAL GROUP INC. Liabilities

Metric Details

Metric: Liabilities (Liabilities)
Taxonomy: ifrs-full
Units tracked: USD and CHF
Frequency coverage: quarterly
History range: 31 Dec 2016 - 31 Dec 2024
Facts on this page: 17
Metric-level SEC endpoint: Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Liabilities, Quarterly (USD)

Liabilities, YoY Quarterly Change (%)

Liabilities, Quarterly (CHF)